NCT06015295View on ClinicalTrials.gov

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 7, 2024

Primary Completion Date

March 30, 2028

Study Completion Date

March 30, 2028

Conditions
Brain Metastases
Interventions
DIAGNOSTIC_TEST

18F-Fluciclovine (Axumin)

Given by Injection

DIAGNOSTIC_TEST

Pet Scan

Scans

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

Blue Earth Diagnostics
All Listed Sponsors
collaborator

Blue Earth Diagnostics

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER